But as Lilly and Alex had started a successful fitness business together called LEAN and built a social media empire, there were still plenty of questions about what would happen to the business ...

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized ...

Shop vibrant dresses, standout activewear, and iconic Lilly Pulitzer prints for 60% off—only for 48 hours. Grab your Lilly Pop-Up Sale favorites now before sizes and styles start selling out fast.

And a third season of Dark Winds is on the way. Jack Shephard (Matthew Fox), Kate Austen (Evangeline Lilly), John Locke (Terry O’Quinn), James “Sawyer” Ford (Josh Holloway), and Sayid Jarrah ...

EVANGELINE PARISH, La. (KLFY) — Two people have been arrested in connection with a series of thefts in which chickens were stolen, authorities said. Brannon Buller, 33, of Ville Platte, is ...

What makes my 45 minute dumbbell workout fly by? Workout headphones, paired with an audiobook, of course. Workout headphones can vary in shape and size. Some look like typically wireless earbuds ...

Lilly Pulitzer (4) Your closet is about to be in bloom! For two days only, Lilly Pulitzer is blossoming with discounts on its cheery dresses, skirts, pants, and more. But this is the only sale ...

Given the potential opportunities in the sector, should investors buy Eli Lilly stock? Here's where the company and its stock stand now. The GLP-1 agonist opportunity is gearing up for its next ...

On Wednesday, pharmaceutical giant Eli Lilly sued four prominent telehealth companies that offer more affordable, off-brand versions of its patented best-selling GLP-1 medications Mounjaro and ...

Eli Lilly's oral GLP-1 medicine aced a phase 3 study. It should become a new growth driver for the company. There are other reasons to invest in the pharmaceutical leader. Zepbound's prospects ...

The weight loss drug market could grow to $500 billion over the next decade. Eli Lilly's next-generation products look promising, while competitors have stumbled in clinical trials. Investors are ...